LSE - Small Logo
LSE - Small Logo

Dipa Patel

Eduardo Mercadante

March 2nd, 2021

Request to stop the extension of pharmaceutical patent periods in Brazil

1 comment

Estimated reading time: 10 minutes

Dipa Patel

Eduardo Mercadante

March 2nd, 2021

Request to stop the extension of pharmaceutical patent periods in Brazil

1 comment

Estimated reading time: 10 minutes

The Brazilian Public Prosecutor cites a paper co-written by PhD student in the Department of International Development, Eduardo Mercadante, in the request that the Supreme Court immediately stop the extension of pharmaceutical patent periods to help fight the COVID-19 pandemic.

In light of the especially hard challenge Brazil is facing with the COVID-19 pandemic, the Public Prosecutor has requested that the Supreme Court immediately eliminate a legal mechanism that extends patent protection periods.

In Brazil, patent protection periods may be longer than the international standard of 20 years from filing, on account of a special clause that guarantees patents a minimum of 10 years of validity from the date of grant. If the patent office takes more than ten years to grant the patent, any extra time beyond ten years is added to the total patent term. Extending periods of patent protection is especially impactful in the pharmaceutical industry, as doing so delays the entrance of generic competition.

Not surprisingly, the clause in Brazil’s patent law that guarantees 10 years of protection is controversial. The Supreme Court is due to decide in May if this should be retained or removed on grounds of being unconstitutional.

In February, the Public Prosecutor (an office in Brazil that represents citizens on constitutional matters) submitted a brief to the Supreme Court recommending that the provision in question be removed immediately (the Public Prosecutor’s submission, in Portuguese).

The Public Prosecutor’s intervention (available here, in Portuguese) relied on and referenced the findings of an article written by Eduardo Mercadante, PhD student in the Department of International Development, and colleagues from the Federal University of Rio de Janeiro. Building on Mercadante’s MA dissertation, which shows 92.2% of pharmaceutical patents granted in Brazil have extended periods of three and a half years on average, the article cited by the Public Prosecutor argues that the removal of the patent extension mechanism could reduce the costs to the Brazilian Universal Health System (SUS) of procuring nine drugs in 56%. This would mean savings of 1.1% of the total cost of SUS per year, which could be very helpful for a country that is battling very high infection and death rates of COVID-19, with a more powerful variant and difficulty to procure vaccines, ventilators, and oxygen tanks.

Here is a link to the article (in Portuguese), and a previous discussion of these issues on the ID Blog.


The views expressed in this post are those of the author and in no way reflect those of the International Development LSE blog or the London School of Economics and Political Science.

About the author

Dipa Patel

Eduardo Mercadante

Eduardo Mercadante is a PhD Candidate in the Department of International Development at the LSE, under the supervision of Professor Ken Shadlen (LSE) and Professor Bhaven Sampat (Columbia). In his PhD thesis, he investigates the role of patent examination in the promotion of the balanced private and public incentives that base the rationale for pharmaceutical patenting, using Brazil as a case study of the challenges of implementing this policy in a developing country.

Posted In: Covid-19 | Featured | Topical and Comment

1 Comments

RSS Justice and Security Research Programme

RSS LSE’s engagement with South Asia

  • Political Economy of Forest Rights in India
    The implementation of forest rights in India has been a complex, and occasionally successful, enterprise. In this post, Tejendra Pratap Gautam examines details of one such successful exercise where community enterprise meets state policy to make it work for communal good, underlining the importance of a ‘political economy’ intervention in development at the grassroots level.  […]
  • Weaving Art and Resistance in Myanmar
    On show in the Atrium Gallery at LSE, ‘Not Another Protest Exhibition: Myanmar in Revolt & Feminist Art Practice’ features the work of Chuu Wai, a multidisciplinary artist from Shan State, Myanmar, now living in Paris. In this post, curator and LSE PhD Research Scholar Sara Wong discusses the historical and socio-political context of contemporary […]